Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (91-100 of 350) with videos related to

Pageof 35
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|April 21, 2018
Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitisTammo L Tergast, Anika Wranke, Hans Laser, et al.
Zeitschrift Fur Gastroenterologie|December 11, 2023
Antiviral Therapy of Chronic Hepatitis D Virus Infection - Addendum to the S3 Guideline "Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection" of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Virology Journal|June 15, 2007
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune responseManuela F Meyer, Marc Lehmann, Markus Cornberg, et al.
Zeitschrift Fur Gastroenterologie|December 11, 2023
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infectionXandra Volkmann, Markus Cornberg, Heiner Wedemeyer, et al.
Zeitschrift Fur Gastroenterologie|October 19, 2021
[Glecaprevir/Pibrentasvir + Sofosbuvir + Ribavirin as a salvage regimen after Sofosbuvir + Velpatasvir + Voxilaprevir re-treatment failure]Tammo L Tergast, Nikolaus Kordecki, Valerie Ohlendorf, et al.
Journal of Hepatology|November 26, 2002
Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis CMarkus Cornberg, Holger Hinrichsen, Gerlinde Teuber, et al.
United European Gastroenterology Journal|September 4, 2020
UEG framework for the development of high-quality clinical guidelinesDoron Boltin, Doenja Mj Lambregts, Fiona Jones, et al.
Journal of Viral Hepatitis|March 16, 2023
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNAKatja Deterding, Chengjian Xu, Kerstin Port, et al.
Cells|June 21, 2020
Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene TechnologiesKatie Healy, Anna Pasetto, Michał J Sobkowiak, et al.
Pageof 35

Showing results (91-100 of 350) with videos related to

Sort By:
Pageof 35
Liver International : Official Journal of the International Association for the Study of the Liver|April 21, 2018
Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitisTammo L Tergast, Anika Wranke, Hans Laser, et al.
Zeitschrift Fur Gastroenterologie|December 11, 2023
Antiviral Therapy of Chronic Hepatitis D Virus Infection - Addendum to the S3 Guideline "Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection" of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Virology Journal|June 15, 2007
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune responseManuela F Meyer, Marc Lehmann, Markus Cornberg, et al.
Zeitschrift Fur Gastroenterologie|December 11, 2023
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infectionXandra Volkmann, Markus Cornberg, Heiner Wedemeyer, et al.
Zeitschrift Fur Gastroenterologie|October 19, 2021
[Glecaprevir/Pibrentasvir + Sofosbuvir + Ribavirin as a salvage regimen after Sofosbuvir + Velpatasvir + Voxilaprevir re-treatment failure]Tammo L Tergast, Nikolaus Kordecki, Valerie Ohlendorf, et al.
Journal of Hepatology|November 26, 2002
Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis CMarkus Cornberg, Holger Hinrichsen, Gerlinde Teuber, et al.
United European Gastroenterology Journal|September 4, 2020
UEG framework for the development of high-quality clinical guidelinesDoron Boltin, Doenja Mj Lambregts, Fiona Jones, et al.
Journal of Viral Hepatitis|March 16, 2023
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNAKatja Deterding, Chengjian Xu, Kerstin Port, et al.
Cells|June 21, 2020
Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene TechnologiesKatie Healy, Anna Pasetto, Michał J Sobkowiak, et al.
Pageof 35